Advanced Oncology & Hematology
Breakthrough CAR-T immunotherapy, proton and heavy-ion radiation, and MDT-driven treatment plans from China's #1 hematology center — at a fraction of Western costs.
Breakthrough Therapies
Frontier oncology modalities previously only available at a handful of global centers — now accessible on an accelerated timeline.
CAR-T Cell Therapy
A leading-edge immunotherapy for refractory leukemia and lymphoma. We provide a specialized clinical pathway: T-cell Collection → Laboratory Engineering → Targeted Infusion.
Proton & Heavy Ion Therapy
Extreme precision targeting. Proton beams are engineered to deposit maximum energy directly at the tumor site, effectively sparing surrounding healthy organs.
The MDT Strategy
Every complex case is reviewed by a multidisciplinary tumor board — surgeons, oncologists, radiologists, and pathologists working in lockstep.
A Collaborative Board of Experts
Every complex case is managed by a specialized committee including Surgeons, Oncologists, Radiologists, and Pathologists.
Personalized Treatment Plans
This collective approach ensures a unified, data-driven strategy designed specifically for your unique clinical profile from day one.
Global Value & Accessibility
Unmatched Economic Advantage: access the world's most sophisticated medical technologies at a fraction of Western costs, with 100% price integrity.
| Treatment | USA / UK | Singapore | Shanghai (Ruijin) |
|---|---|---|---|
| CAR-T Therapy | $400k – $500k | $250k+ | $80k – $120k |
| Proton Therapy | $100k – $150k | $80k+ | $40k – $50k |